Clinical Trials Directory

Trials / Completed

CompletedNCT00997269

Benefit of CoQ-10 in Patients on Statins

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Stony Brook University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study will investigate whether a supplement called co-enzyme Q10 can help ease or eliminate some of the side effects that result from taking statin medications. These side effects include muscle pain, fatigue or muscle cramping.

Detailed description

Specific Aim 1: to demonstrate that supplementation with coQ10 in patients treated with statins ameliorates symptoms of muscle pain and fatigue and improves energy metabolism and muscle function. This objective will be achieved in a randomized, placebo-controlled double blind trial by assessing the degree of muscle symptoms and interference of pain with daily activities, aerobic capacity, and muscle function before and after supplementation with either coQ10 or placebo in groups of statin-treated subjects. Specific Aim 2: to examine changes at a molecular/cellular level that are associated with improved pain and muscle function in statin-treated subjects supplemented with coQ10. This aim will be addressed by analyzing muscle biopsies taken from statin-treated patients before and after supplementation with coQ10 or placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCo-enzyme Q-10Patients will be supplemented with 300 mg of CoQ-10 1 time daily for one month
DIETARY_SUPPLEMENTPlaceboPatients will be supplemented with CoQ-10 placebo 1 time daily for one month

Timeline

Start date
2009-09-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2009-10-19
Last updated
2016-05-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00997269. Inclusion in this directory is not an endorsement.